Dr. Arun Chawla, MD

Dr. Chawla practices at U.S. Renal Care Gloucester Dialysis in Hammonton, New Jersey.

Dr. Chawla's NPI, 1568611630, was assigned on September 15, 2008. Dr. Chawla graduated from Maulana Azad Medical College in 2005. Dr. Chawla holds New Jersey license 25MA09830600.

Dr. Chawla's primary practice is U.S. Renal Care Gloucester Dialysis, at 777 White Horse Pike, Hammonton, NJ 08037 in Atlantic County. The practice phone is (848) 202-3080.

Dr. Chawla's primary practice is U.S. Renal Care Gloucester Dialysis in Hammonton, New Jersey. Dr. Chawla is also affiliated with Cooper University Hospital. The medical group on file is Advocare. Dmand AI also links Dr. Chawla to 4 more hospitals, 3 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chawla practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Chawla's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Chawla is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Chawla's licenses on file in 3 states: New Jersey, Virginia and Pennsylvania.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia, kidney cysts and parathyroid gland disorder among the conditions Dr. Chawla treats.

CMS data shows 2,168 Medicare services from Dr. Chawla across 9 procedure codes in 2024, for 366 Medicare patients. Medicare paid $175,321 for them.

CMS counts 366 Medicare patients who saw Dr. Chawla in 2024. The largest group is 65 to 74, with 135 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 23% are also on Medicaid. Their average risk score is 3.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chawla's median patient age at 70, with 42% women.

In 2024, Dr. Chawla wrote 1,487 Medicare Part D claims for 251 patients. 86% of them were for generic drugs. CMS names the drug for 1,223 of them, across 34 drugs with 11 or more claims each, at $218,463 in total drug cost. In 2023, CMS named 1,551 claims across 34 drugs.

Dr. Chawla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chawla as offering telehealth.

Dmand AI links 27 papers to Dr. Chawla, published from 2010 to 2025. 2013 was the busiest year, with 4. The most frequent topics are Nephrolithotomy, Percutaneous, Kidney Calculi and Nephrology. Dr. Chawla has published most often in Ren Fail. Dr. Chawla's most frequent co-authors are Kenar Dinesh Jhaveri, MD, Ankit Agarwal, MD and Rtika Ryfka Abraham, MD.

Dmand AI links Dr. Chawla to 1 clinical trial.

CMS Open Payments shows 51 general payments to Dr. Chawla from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. AstraZeneca Pharmaceuticals LP paid the most, $343.

Dmand AI lists 4 awards for Dr. Chawla, most recently Lawrence Scherr, MD Department of Medicine Scholarly Activity Awards, Research/Paper Category in 2011.

Dr. Chawla graduated from Maulana Azad Medical College in 2005.

Dr. Chawla is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.